Market cap
$2,771 Mln
Revenue (TTM)
$514 Mln
P/E Ratio
48
P/B Ratio
5.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 2.21 | 15.77 | 17.76 | 20.54 | 18.20 |
| EBIT | -44.07 | -72.70 | 136.37 | -16.89 | 25.43 |
| Net Profit | -41.75 | -67.29 | 138.93 | 50.97 | 21.21 |
| EPS | -41.92 | -67.78 | 130.53 | 44.99 | 14.29 |
| Book Value | -- | -- | 41.76 | 71.29 | 41.38 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -24.27 | 1.07 | 17.71 | 19.17 | -68.78 |
| Net Margin
| -- | -- | 11.43 | -- | -- |
| Return on equity
| -94.62 | 8,972.54 | 11.49 | 19.10 | -152.88 |
| Return on Capital
| -80.91 | -43.40 | -- | 18.34 | -143.18 |
| Return on Assets
| -17.99 | -0.24 | 4.39 | 9.61 | -46.26 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.05 | 0.03 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
18.34
|
-143.18
|
-117.91
|
1,522.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
11.49
Higher than Peers by 13.27
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
11.49
|
19.10
|
-152.88
|
-150.08
|
46,642.86
|
|
Peer Median
|
-1.77
|
--
|
--
|
--
|
--
|
ROA
4.39
Higher than Peers by 5.45
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
4.39
|
9.61
|
-46.26
|
-17.33
|
32.51
|
|
Peer Median
|
-1.06
|
--
|
--
|
--
|
--
|
EBIT Margin
17.71
Higher than Peers by 19.16
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
17.71
|
19.17
|
-68.78
|
-23.20
|
44.67
|
|
Peer Median
|
-1.45
|
--
|
--
|
--
|
--
|
Net Margin
11.43
Higher than Peers by 13.78
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
11.43
|
16.47
|
-70.54
|
-24.95
|
44.63
|
|
Peer Median
|
-2.36
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
17.76
Higher than Peers by 4.66
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
17.76
|
0.19
|
0.23
|
0.20
|
0.10
|
|
Peer Median
|
13.10
|
--
|
--
|
--
|
--
|
EBIT Growth
136.37
Higher than Peers by 105.06
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
136.37
|
133.05
|
-265.88
|
-162.38
|
46.63
|
|
Peer Median
|
31.30
|
--
|
--
|
--
|
--
|
Net Profit Growth
138.93
Higher than Peers by 113.87
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
138.93
|
127.68
|
-248.96
|
-167.13
|
69.20
|
|
Peer Median
|
25.06
|
--
|
--
|
--
|
--
|
EPS Growth
130.53
Higher than Peers by 101.69
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
130.53
|
1.27
|
-1.74
|
-1.67
|
0.75
|
|
Peer Median
|
28.85
|
--
|
--
|
--
|
--
|
Book Value Growth
29.77
Higher than Peers by 22.08
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
29.77
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.68
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
0.05
|
0.03
|
0.41
|
0.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
0.01
|
0.01
|
0.01
|
0.15
|
0.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.60
Lower than Peers by 0.23
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
1.60
|
1.56
|
1.92
|
1.66
|
1.42
|
|
Peer Median
|
1.83
|
--
|
--
|
--
|
--
|
Quick Ratio
1.58
Lower than Peers by 0.22
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
1.58
|
1.54
|
1.89
|
1.62
|
1.38
|
|
Peer Median
|
1.79
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
174.38
|
-0.79
|
-534.91
|
811.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
21.54
Higher than Peers by 2.87
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
21.54
|
22.07
|
20.53
|
23.77
|
29.10
|
|
Peer Median
|
18.67
|
--
|
--
|
--
|
--
|
Asset Turnover
0.38
Lower than Peers by 0.10
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
0.38
|
0.58
|
0.66
|
0.69
|
0.73
|
|
Peer Median
|
0.49
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
71.92
|
72.66
|
87.65
|
98.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
40.19
|
55.08
|
69.01
|
60.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
67.81
|
56.48
|
44.24
|
50.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
44.30
|
71.26
|
112.42
|
107.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
48.04
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
48.04
|
57.89
|
-19.25
|
-20.76
|
6.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
5.27
Higher than Peers by 0.40
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
5.27
|
9.36
|
16.22
|
49.22
|
11.38
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
23.43
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
23.43
|
39.98
|
-18.89
|
-21.33
|
5.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
2,771
Higher than Peers by 2,670
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
|
2,771
|
--
|
--
|
--
|
--
|
|
Peer Median
|
101
|
--
|
--
|
--
|
--
|